Adam Walker’s Pharma Prescribed Podcast

Adam Walker’s Pharma Prescribed Podcast

By Adam WalkerBusinessScienceManagementLife Sciences
Download on the App Store

Adam Walker’s Pharma Prescribed Podcast episodes

  • She Found Undiagnosed Children With AI. They're Alive in Their Twenties Now.

    Dr. Andree Bates on Pharma AI, Saving Lives with Data, HelloFresh of Medicine | Pharma Prescribed

    Dr. Andree Bates — founder and CEO of Eularis and 22-year veteran of pharmaceutical AI — joins Adam Walker for the most technically visionary conversation on the Pharma Prescribed Podcast.

    Andree grew up in Papua New Guinea and Japan, holds a PhD in neuroscience, and built machine learning models in her lab before most people knew what AI stood for. She digitized her first pharma company after telling the chairman what was wrong on the bullet train to Osaka. He said: "Fix it."

    She's been fixing things ever since — from 94.8% market share prediction to finding undiagnosed ultra-rare disease children who are now alive in their twenties.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/0ysC8NreYCBq4Co8uEaeaB?si=81Wh-bPGQL20EoAZtRYSng
    Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-dr-andr%C3%A9e-bates-ceo-of/id1829715970?i=1000735563632
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://www.podbean.com/ew/pb-fpdvw-19aceff

    📖 WHAT WE COVER

    - The bullet train story: told the chairman what was wrong — he said fix it
    - Papua New Guinea to Japan to London to New York: adaptability as superpower
    - 94.8% accuracy predicting market share across thousands of brands
    - Finding undiagnosed ultra-rare toddlers — now alive in their twenties
    - Third-line cancer: triangulating EHR and claims data to find the doctor
    - AI strategy blueprints: 50% off-the-shelf, 50% needs building
    - Grail blood test: predicting 50+ cancers with no symptoms
    - Brain cells on computer chips — Cortical Labs and Amazon
    - Non-invasive brain interface letting paralysed people communicate in an hour
    - Digital twins, personalised medicine and the HelloFresh of pharma
    - "Trust the vision, be patient, be kinder to yourself during setbacks"

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Dr. Andree Bates — founder of Eularis
    2:00 PhD neuroscience and ML in the lab
    3:00 Papua New Guinea, Japan and why impact matters now
    4:00 The bullet train: telling the chairman on day one
    5:00 Digitizing pharma in Tokyo — world firsts with Glaxo
    6:00 Starting Eularis: Pfizer in New York as first client
    7:00 "50% of my marketing's wasted — fix that"
    8:00 Ultra-rare disease: finding undiagnosed toddlers with AI
    9:00 Those children are in their twenties now — alive
    10:00 Cultural adaptability across countries
    11:00 AI inflection points: GANs, data explosion, transformers
    13:00 LLMs won't last — what comes next
    14:00 Patient data privacy and federated learning
    16:00 Third-line cancer: triangulating EHR and claims data
    18:00 First, second, third line treatment explained
    19:00 Elite AI teams: top 20 data scientists, 13 joined
    21:00 Data scientists, engineers, DevOps and scrum
    22:00 AI strategy blueprints: how Eularis advises pharma
    24:00 50% off-the-shelf, 50% build
    26:00 Training: the "LLMs are rubbish" moment
    28:00 Jobs fear: saving hours without cutting people
    30:00 Advice for the next generation
    32:00 The Uber driver and the PhD intern from Uganda
    33:00 Andree's vision — 12 hours in Virginia airport
    34:00 Grail: 50+ cancers from a single blood draw
    35:00 The listener who said "you saved my life"
    36:00 Non-invasive brain interface vs Neuralink
    38:00 Brain cells on chips: Cortical Labs and Amazon
    39:00 Digital twins powered by your own brain
    40:00 HelloFresh of pharma: 3D printed personalised drugs
    42:00 Quick-fire: trust the vision but be patient
    44:00 Curiosity, patient centricity, comfort with ambiguity
    46:00 Flying, sailing and the Mekong Delta
    48:00 Golden rule: do work that matters with people who matter

    👤 ABOUT DR. ANDREE BATES

    Founder and CEO of Eularis. PhD neuroscience. 22 years in pharma AI. Pilot. Weekly newsletter on AI and life sciences.
    💼 Search "Dr Andree Bates" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #AndreeBates #Eularis #AIinPharma #PharmaceuticalAI #PharmaPrescribed #AdamWalker #RareDisease #DigitalTwins #Grail #CancerDiagnostics #MachineLearning #DrugDiscovery #LifeSciences #Neuroscience #FederatedLearning

    50 min
  • The Two Things Alcohol Quietly Steals: Clarity and Consistency

    Paul McCormack on Sobriety, Untapped Performance & Why Alcohol Steals Your Best Self | Pharma Prescribed

    Paul McCormack — founder of Intention Performance and creator of the Untapped Performance Project — joins Adam Walker for the most personally resonant conversation on the Pharma Prescribed Podcast.

    Paul grew up in the west of Scotland, where alcohol was the reward you earned with age. For nearly 20 years it was the connector — work drinks, football clubs, expat life in London and Sydney. Every October he'd take 30 days off, feel amazing, then count down to November 1st and four bottles of wine. Until COVID, a puppy called Rolo, and a 5am wake-up changed everything.

    He hasn't had a drink in five years. Neither has Adam. This is that conversation.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/4Vnz2NR4rk727FTukW4REI?si=oCtRjGIbRpeTpK_D3LYcMA
    Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-paul-mccormack-founder-coach/id1829715970?i=1000733878494
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://www.podbean.com/ew/pb-gix2g-19a7efa

    📖 WHAT WE COVER

    - The October ritual: 30 days off, four bottles of wine waiting on November 1st
    - COVID, a bottle of wine every night for six weeks, and a puppy called Rolo
    - From 30 days to 100 to a year — and the 126 YouTube videos that got him there
    - Stag do sober: how the guy who'd have called you insane did it and loved it
    - FOMO to JOMO: the fear of missing out becomes the joy of missing out
    - Fat Boy Slim sober: Adam's story from last night — two drank, two didn't, same joy
    - Alcohol as an anesthetic: what it actually does to your senses
    - Clarity and consistency: the two things alcohol steals that matter most
    - The Untapped Performance Project: 30 days on alcohol, then performance coaching
    - Ryan Parke's Future Self Program and Monday Morning Men's Club
    - Coaching as the unsexiest, most effective investment you can make
    - Atomic Habits and compound gains from daily sober decisions
    - "Don't take yourself too seriously" — the golden rule

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Paul McCormack — founder of Intention Performance
    2:00 Working with growth-minded men at 50-70% capacity
    3:00 Growing up in Scotland: alcohol as a reward earned with age
    4:00 University, London, Sydney — alcohol as the connector everywhere
    5:00 The October ritual: 30 days off, four bottles waiting
    6:00 Adam's own relationship with alcohol
    7:00 COVID: a glass of wine every night for six weeks
    8:00 Rolo the puppy and the 5am wake-up that changed everything
    9:00 From 30 days to 100 — and 126 YouTube videos in the gap
    10:00 The switch: logical reasons plus physical and mental benefits
    11:00 First birthday sober since age 17
    12:00 Career: journalism dream, HSBC, online gaming, marketing
    14:00 Moving to Sydney at 27 with one suitcase
    15:00 Going full-time coaching in 2024
    16:00 The Future Self Program with Ryan Parke
    17:00 Monday Morning Men's Club and goal setting
    18:00 Adam's podcast origin story — born from the Future Self Program
    20:00 The Untapped Performance Project explained
    21:00 First 30 days: deep dive into the alcohol relationship
    22:00 Values alignment and confronting the truth
    23:00 FOMO to JOMO
    24:00 Fat Boy Slim last night: two sober, two drinking, same experience
    26:00 Alcohol as anesthetic — what it does to your senses
    27:00 The stag do: sober, FaceTime with dad, pan au chocolat
    28:00 Compound gains from showing up every day without alcohol
    30:00 Clarity and consistency — the two things alcohol takes
    32:00 Coaching: being listened to without someone scrolling their phone
    34:00 Therapy, dog walks and investing time in yourself
    36:00 Coaching for everyone — not just execs
    37:00 Alcohol break + coaching = most productive three months ever
    38:00 Quick-fire: trust the process
    39:00 Authenticity, listening and openness to feedback
    40:00 Golden rule: don't take yourself too seriously
    41:00 How to connect: LinkedIn and untappedperformanceproject.com

    👤 ABOUT PAUL MCCORMACK

    Paul McCormack is founder of Intention Performance and creator of the Untapped Performance Project. Five years alcohol-free. Based in Sydney.
    🌐 https://www.untappedperformanceproject.com
    💼 Search "Coach Paul McCormack" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #PaulMcCormack #IntentionPerformance #AlcoholFree #Sobriety #PharmaPrescribed #AdamWalker #UntappedPerformance #MensMentalHealth #JOMO #FOMO #FutureSelf #RyanParke #AtomicHabits #Coaching #Wellbeing

    42 min
  • A Chance Airport Conversation Became a Global Deal in a Year and 26 Days

    Sverre Bengtsson on Building Viedoc, the Paris Airport Deal & Why Europe Must Work Together | Pharma Prescribed

    Sverre Bengtsson — co-founder of Viedoc Technologies, ACDM board member and angel investor in 30+ life science ventures — joins Adam Walker for a conversation about building a global eClinical platform from a blank sheet of paper.

    Sverre trained as a statistician in Sweden, got lured into clinical research by someone who said "you know a bit of statistics, can't you do things here?" — and never left. When his CRO employer hit hard times, he and co-founder Hendrik built their own EDC system, not for others, but for themselves. Competitors asked to use it. Then a chance encounter in a Paris airport lounge led to a global pharma deal that changed everything.

    Viedoc now operates across 80+ countries. Sverre is focused on investing in the next generation.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/7zSgUe1f80Bd483P9G8JuK?si=BQd1aCmAQoCnhMcdpxYl5Q
    Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-sverre-bengtsson-digital-first/id1829715970?i=1000733465389
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://www.podbean.com/ew/pb-7gjtb-19a3574

    📖 WHAT WE COVER

    - Built an EDC system from a blank sheet of paper in 2003 — for themselves, not clients
    - Competitors asked to use it — and Viedoc was born
    - The Paris airport lounge: spotting a woman working on a pharma PowerPoint, demoing the system on the spot
    - One year and 26 days: from lounge conversation to global pharma contract
    - Splitting the CRO from the tech company — and why it had to happen for Viedoc to take off
    - AI is hitting clinical operations first: protocols, trial management, feasibility analysis
    - "We overestimate the short-term effects but underestimate the long-term effects"
    - The radiologist problem: AI gets smarter, humans get lazier — and we lose knowledge
    - Why a knowledge-intensive industry must keep attracting new talent even as AI scales
    - ACDM, EUCROF and why volunteering matters
    - Europe's fragmentation, competitiveness and the geopolitical imperative to work together
    - 30+ angel investments across European life sciences
    - Be humble. Do your best.

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Sverre Bengtsson — co-founder of Viedoc Technologies
    2:00 Statistics, economics and how he got lured into clinical research
    3:00 Building Viedoc from a blank sheet of paper in 2003
    4:00 Competitors wanted to use it — the accidental product company
    5:00 Can't thank your first clients enough
    6:00 The Paris airport lounge: demoing Viedoc to a pharma executive
    7:00 One year and 26 days to sign the global deal
    8:00 60 pages of contract — the first time at that level
    9:00 Splitting the CRO from the tech company — the hard decision
    10:00 Firewall, trust and why the CRO had to be sold
    11:00 Focus: the moment Viedoc truly took off
    12:00 Scaling globally: 24/7 support, multiple IT centres, 80+ countries
    13:00 AI hitting clinical operations first — protocols and feasibility
    14:00 Live monitoring of operational and data quality
    15:00 Conservative industry or inflection point? Both are right
    16:00 Three to five years before this is mainstream
    17:00 The radiologist problem: AI improves, human knowledge declines
    18:00 Why we must keep attracting new talent into clinical research
    19:00 The sweet spot of medical information, data and tech
    20:00 Think outside the checklist
    21:00 Mentors: MiniDoc founders and the CEO who made him stay
    22:00 The balance between nerd and communicator
    23:00 People in this industry genuinely burn for what they do
    24:00 ACDM: how he got involved through volunteering
    25:00 EUCROF: promoting the European perspective
    26:00 Europe's challenges: fragmentation, competitiveness and unity
    27:00 Geopolitics and working together globally
    28:00 ACDM as a model for the world
    29:00 Quick-fire: focus — his wife would agree
    30:00 Golden rule: be humble, do your best

    👤 ABOUT SVERRE BENGTSSON

    Co-founder of Viedoc Technologies. ACDM board member. EUCROF member. Angel investor in 30+ European life science ventures. Statistician by training.
    💼 Search "Sverre Bengtsson" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #SverreBengtsson #Viedoc #EDC #ClinicalTrials #ACDM #PharmaPrescribed #AdamWalker #eClinical #LifeSciences #ClinicalDataManagement #AngelInvestor #BiotechStartup #Europe #EUCROF #AIinPharma

    31 min
  • 60% of Patients Would Join a Trial. Only 8% Do. She Fixes It in 5 Minutes

    Nuria Coll Bastus on ClinicalNet, Trial Matching in 5 Minutes & Why 80% of Trials Are Delayed | Pharma Prescribed

    Nuria Coll Bastus — founder and CEO of ClinicalNet — joins Adam Walker for a conversation about why 80% of clinical trials are delayed by recruitment, and how one platform could change that.

    Nuria has a PhD in onco-genomics from Barts Cancer Institute, spent years in pharma, and kept getting calls from friends and family: "Can you find a clinical trial for my loved one?" She could — but it took six hours. That disconnect became her MBA dissertation, then her startup, then her life's work.

    ClinicalNet matches patients with clinical trials in under five minutes. Free. Globally.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/6WpliuhaXzpXMgUXufcM5T?si=70dccc836434431e
    Apple Podcasts → https://podcasts.apple.com/us/podcast/nuria-coll-bastus-on-clinicalnet-trial-matching-in/id1829715970?i=1000732142862
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://pharmaprescribed.podbean.com/

    📖 WHAT WE COVER

    - 60% of patients would consider a trial, but only 8% enter one — why?
    - Six hours to search using expert skills most patients don't have
    - ClinicalNet: matching in under five minutes, free, all indications
    - 65,000 open trials structured by AI — why three AI teams failed before Nuria solved it
    - The Barcelona oncologist who didn't know about two melanoma trials next door
    - Nuria's mother diagnosed with metastatic melanoma — the personal story
    - Updated every 24 hours: new trials surfaced automatically
    - Less than 10% of traditional recruitment cost — fully automated
    - Clinical trials as a day-one treatment option, not a last resort
    - Don't give up — the golden rule

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Nuria Coll Bastus — founder of ClinicalNet
    2:00 Chemistry in Barcelona to onco-genomics PhD at Barts
    3:00 The disconnect: patients looking, trials struggling
    4:00 MBA dissertation becomes a startup
    5:00 Summer 2021: leaving pharma for the mission
    6:00 Understanding business as much as science
    7:00 Only 20% of patients try a second search
    8:00 What families actually experience looking for trials
    9:00 ClinicalNet: five minutes, lay and medical language
    10:00 Building the AI — three teams failed before Nuria solved it
    11:00 Why LLMs alone can't process 65,000 trials at scale
    12:00 Breaking down data from a medical perspective
    13:00 "Not pregnant" vs "negative HCG test" — the data problem
    14:00 Free for patients, doctors and academic trials — always
    15:00 Updated every 24 hours with new trials
    16:00 Pharma pays: less than 10% of traditional recruitment cost
    17:00 No army of PhDs — everything automated
    18:00 When all three user groups connect, it works
    20:00 Three years to build a scalable platform
    21:00 Profitability expected within nine to twelve months
    22:00 The colleague whose husband had metastatic gastric cancer
    24:00 Nuria's mother and the Barcelona melanoma diagnosis
    25:00 The oncologist who didn't know about two nearby trials
    26:00 "It's the job of the family to take care of your own health"
    28:00 Patients already entering trials through ClinicalNet
    29:00 Trials as day-one options, not last resort
    30:00 Taking ownership of health outcomes
    33:00 NIHR conversations and NHS app potential
    35:00 Quick-fire: don't be scared — start sooner
    36:00 Motivation for impact, honesty, positivity
    37:00 Sport — any sport
    38:00 Golden rule: don't give up

    👤 ABOUT NURIA COLL BASTUS

    Founder and CEO of ClinicalNet. PhD onco-genomics (Barts). 12+ years in drug development.
    🌐 https://www.clinicalnet.com
    🔍 https://trials.clinicalnet.com (free patient search)
    💼 Search "Nuria Coll Bastus" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #NuriaCollBastus #ClinicalNet #PatientRecruitment #ClinicalTrials #PharmaPrescribed #AdamWalker #HealthTech #OncoGenomics #CancerTrials #PatientAccess #DrugDevelopment #LifeSciences #AIHealthcare #FemaleFounder #Barcelona

    39 min
  • How to Predict a Trial's Failure Before It Happens (Using Fraud-Detection Maths)

    Artem Adrianov on RBQM, Fraud Detection & the Young CEO Programme That Outperforms an MBA | Pharma Prescribed

    Artem Adrianov — co-founder and CEO of CluePoints (SEG Integrity) and author of the Definitive Guide to RBQM — joins Adam Walker for a conversation about risk, quality, fraud detection and what it really means to build a company from its values up.

    Artem holds a PhD in mathematical modelling and an Executive MBA from Cass Business School. He started by asking a simple question: how do you detect fraud in clinical trials? That led to Benford's Law, algorithms from the finance industry, and eventually a company that now manages risk across thousands of studies with 50 employees.

    He also runs a Young CEO programme that has produced better leaders than any MBA — and the idea came from his wife's experience at Eli Lilly.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/5QsRaLzQgpZNhGn4Ru2cxO?si=e5c01721e0c846a5
    Apple Podcasts → https://podcasts.apple.com/us/podcast/artem-adrianov-on-rbqm-fraud-detection-the-young-ceo/id1829715970?i=1000728560133
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://pharmaprescribed.podbean.com/

    📖 WHAT WE COVER

    - Fraud detection in pharma: Benford's Law and algorithms borrowed from finance
    - "Bloomberg for pharma" — the vision for SEG Integrity
    - The airplane analogy: 8 out of 10 flights delayed, 2 crash, and the price keeps doubling
    - ICH E6 R3 knocking on the door — why the regulatory shift forces transformation
    - The Young CEO programme: two years, psychologists, journaling and real strategic decisions
    - 2–3% retention rate — and why internal promotion beats hiring from outside
    - Founder-owned, self-funded and thinking long-term in a short-term industry
    - "Reduced based monitoring" — what sites actually think RBM stands for
    - Quality by design: why step-by-step always beats big bang
    - Four-day quarterly fasting for clarity of mind — and what Socrates knew
    - My RBQM Academy: 1,500+ professionals trained from 400+ organisations
    - Piano, Sinatra's "My Way" and Bach played in jazz mode

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Artem Adrianov — co-founder of SEG Integrity
    2:00 Four-day quarterly fasting for clarity of mind
    3:00 Socrates, energy waves and hidden potential
    4:00 Founding SEG: medicine, mathematics and solving challenging problems
    5:00 Fraud detection in clinical trials — borrowing from finance
    6:00 Benford's Law and digital repeatability algorithms
    7:00 Every risk needs its own dedicated approach
    8:00 Leadership style: removing roadblocks, not pointing fingers
    9:00 The Young CEO programme explained
    10:00 Real strategic decisions: "will you sign this contract?"
    11:00 Why internal young leaders outperform hired-in managers
    12:00 Two years, psychologists, journaling and transformation
    13:00 Culture gets cemented through internal promotion
    14:00 Apprenticeship model: learning through real decisions
    15:00 Opening the programme to external participants
    16:00 Eli Lilly and Johnson & Johnson as inspiration
    17:00 AI and scaling: 50 people managing thousands of studies
    18:00 ICH E6 R3 and why transformation is now mandatory
    19:00 Revenue growth and 200–300 employees within two years
    20:00 The airplane analogy: 8 out of 10 flights delayed, 2 crash
    21:00 Comparing pharma to aviation safety standards
    22:00 Bloomberg for pharma — transparent, benchmarked, insight-driven
    23:00 Mutual decision-making, not finger pointing
    24:00 Darwin: not the smartest, not the strongest — the most adaptable
    25:00 Step-by-step always beats big bang in RBQM
    26:00 "Reduced based monitoring" — what sites actually hear
    27:00 Lessons as a founder: you can't do everything yourself
    28:00 Quality in everything: ideas, implementation, delivery
    29:00 Company fasting: reflecting on whether you deliver the best value
    30:00 Quick-fire: believe in what you're doing despite all other opinions
    31:00 Passion, patient stories and why you have to be a bit crazy
    32:00 Piano, grand piano and everything with keys
    33:00 Sinatra's "My Way" and Bach in jazz mode
    34:00 Golden rule: stay integrated — doing the right thing when nobody's watching

    👤 ABOUT ARTEM ADRIANOV

    Co-founder and CEO of SEG Integrity. PhD mathematical modelling. Executive MBA (Cass). Author of the Definitive Guide to RBQM. Creator of My RBQM Academy (1,500+ professionals trained).
    🌐 https://www.integrity.com
    💼 Search "Artem Adrianov" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #ArtemAdrianov #SEGIntegrity #RBQM #QualityByDesign #ClinicalTrials #PharmaPrescribed #AdamWalker #FraudDetection #ICHE6R3 #ClinicalResearch #RiskManagement #YoungCEO #DataQuality #LifeSciences #CentralizedMonitoring

    43 min
  • 4:45am, February 24th, 2022: Running Clinical Trials Through a War

    Dr. Anna Titkova on Building Clinical Trials in Ukraine War, COVID & Restarting | Pharma Prescribed

    Dr. Anna Titkova — International Operations Director at Pratia and former Country Head of Pratia Ukraine — joins Adam Walker for one of the most deeply human conversations on the Pharma Prescribed Podcast.

    Anna built Pratia Ukraine from scratch during COVID — registering two companies, establishing eight embedded clinical research units across four cities, randomising nearly 500 patients in a COVID vaccination trial. Then at 4:45am on February 24th, 2022, everything changed. Nearly 1,500 days later, she is still leading, still building, and still putting patients first — now from Poland.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/2zrjVn8j43Lqr4KaH7dM5a?si=oth7wUsURXm1Q4rEqWh40w
    Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-anna-titkova-international/id1829715970?i=1000728557029
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://www.podbean.com/ew/pb-xgyvx-19770e6

    📖 WHAT WE COVER

    - Building Pratia Ukraine from zero during COVID — eight sites, four cities, three regions
    - The first dedicated private clinical research institution in Ukraine
    - 4:45am, February 24th, 2022 — and the 1,500 days that followed
    - Relocating to Poland and rebuilding from a new country
    - COVID as unconscious disaster recovery training for what came next
    - 70 new trials approved in Ukraine in six months — approaching pre-war numbers
    - "I wish I'd never told you this story" — the Oscar speech that frames everything
    - Being a professor, a doctor, a mother and a business leader simultaneously
    - Post-Soviet heritage: the bureaucratic reality of registering a clinical research site
    - Why she still uses a paper list — and the satisfaction of crossing things off
    - Patient centricity is not a phrase — it's access to innovative treatments wherever you are
    - Warren Buffett on hiring: honesty, intelligence, energy — without the first, the rest don't matter
    - 70 countries visited and what travel teaches about how small our worries really are
    - You cannot take from the world more than you give to it

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Dr. Anna Titkova — International Operations Director, Pratia
    2:00 1,500 days since the invasion — "we used to it now"
    3:00 Born in Kharkiv — relocated to Poland
    4:00 What Pratia does: an international site management organisation
    5:00 Building Pratia Ukraine from 2019 — eight sites, four cities
    6:00 Registering two companies during COVID lockdown
    7:00 World best recruitment in a COVID treatment study — 500 patients
    8:00 COVID as unconscious disaster recovery training
    9:00 Adapting to impossible conditions — no transport, no notary, no normal
    10:00 Family and purpose: a childhood dream to become a doctor
    11:00 No businessman in the family — a post-Soviet mindset
    12:00 "Your purpose is the rock you cannot imagine not doing"
    13:00 Combining professor, doctor, mother and operations director
    14:00 Cultural differences between Ukrainian legislation and EU standards
    15:00 Paper lists and the satisfaction of crossing things off
    16:00 Clinical trials in Ukraine today — 70 new approvals in six months
    17:00 Sponsors remembering Ukraine's potential as a rescue country
    18:00 Speaking at conferences and sharing the Ukrainian story
    19:00 Operational excellence inside a site network
    20:00 Resilience: not never falling, but rising with sharper vision
    21:00 "The life has its own plans — and it humbles you"
    22:00 "I wish I'd never made this film" — the Oscar speech
    23:00 The future of Pratia and Anna's personal mission
    24:00 Patient centricity means access — not a poster on a wall
    25:00 Quick-fire: believe in yourself, no matter how impossible
    26:00 Warren Buffett: honesty, intelligence, energy
    27:00 Traveling 70 countries — how small our worries really are
    28:00 Golden rule: you cannot take more than you give

    👤 ABOUT DR. ANNA TITKOVA

    International Operations Director at Pratia. Former Country Head, Pratia Ukraine. Associate Professor. Doctor. Mother.
    🌐 https://www.pratia.com
    💼 Search "Anna Titkova" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #AnnaTitkova #Pratia #Ukraine #ClinicalTrials #PharmaPrescribed #AdamWalker #SiteNetwork #Resilience #PatientAccess #ClinicalResearch #LifeSciences #WarAndResearch #COVID #Kharkiv #Poland

    36 min
  • "You Don't Have to Be Like Everybody Else": The Mentor Who Built a Market

    Natalie Douglas on Building Companies, Leading & Why Mentorship Changed Everything | Pharma Prescribed

    Natalie Douglas — former CEO of Healthcare at Home, creator of the managed access market and Adam's mentor — joins Adam Walker for one of the most personally significant conversations on the Pharma Prescribed Podcast.

    Natalie started carrying the bag at Janssen Pharmaceuticals. She was the only person on her training course without a biochemistry degree. Her trainer told her: "You don't have to be like everybody else." She wasn't — and she went on to build Idis (now Cgen) into the global market leader in managed access, secured private equity backing as one of the first women to do so in pharma services, and led a major turnaround at one of Europe's largest clinical homecare providers.

    Adam calls her a mentor and a friend. This episode is their first recorded conversation.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/6oHY5Z6JCAH6WpTIfd7ZD8?si=0LhnnA7HR86yeRB-YgvbSg&nd=1&dlsi=8a0e45d2c556441c

    Apple Podcasts → https://podcasts.apple.com/us/podcast/you-dont-have-to-be-like-everybody-else-the-mentor/id1829715970?i=1000728052225 

    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://pharmaprescribed.podbean.com/

    📖 WHAT WE COVER

    - Carrying the bag at Janssen — and the trainer who said "just be yourself"
    - Building Idis into a global market leader in managed access
    - "Some people thought it might be illegal" — and how that market now serves millions
    - First women in pharma services to secure PE backing — and why she wouldn't have been taken seriously with a smaller P&L
    - Healthcare at Home: 150,000 patients a year and a turnaround under pressure
    - Courage, confidence and calm — what leadership looks like in a storm
    - Neurodiversity as a creative superpower
    - Mentoring more men than women — and why she responds to every single request
    - Leading from the back: what non-exec and chair roles taught her about quiet leadership
    - Real world evidence in 2011 — and why it still hasn't moved fast enough
    - "It's not a give back — it's a skillset that needs to be used"
    - Trust, honesty, commitment and pace — the four fundamentals

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Natalie Douglas — mentor, friend, industry legend
    2:00 How Adam and Natalie first connected in 2011
    3:00 From Janssen sales rep to building Idis
    4:00 Real world evidence in 2011 — and where it is today
    5:00 Reality (now Cgen) and the pandemic pivot
    6:00 What drives Natalie: natural curiosity, energy and a busy brain
    7:00 Neurodiversity and creativity — "my brain hooks onto things others don't"
    8:00 An explorer who loves people and asks a lot of questions
    10:00 Early mentors: Sue Webb, Jane Griffiths, Liz Norton, Sadie Hartley
    11:00 Family of sole traders — landing at J&J was intimidating
    12:00 The only person without a biochemistry degree
    13:00 "You don't have to be like everybody else"
    14:00 Women in pharma leadership — then and now
    16:00 Mentoring more men than women — honest feedback as a distinctive trait
    17:00 First woman to secure PE backing in pharma services
    18:00 "It takes courage to reach out and ask for help"
    20:00 Honesty, listening, sense of humour — traits of great leadership
    22:00 Healthcare at Home turnaround: courage, confidence and calm
    24:00 Leading from the back — what non-exec taught her
    26:00 Global Genes, British Growth Fund and how each role found her
    28:00 Family, Switzerland, London, the US — an international unit
    30:00 Quick-fire: find your mentors — 10 years earlier than I did
    31:00 Trust, honesty, commitment and pace
    32:00 Basketball, cooking, art, learning Italian
    33:00 Golden rule: do something amazing — make a difference

    👤 ABOUT NATALIE DOUGLAS

    Former CEO of Healthcare at Home and Idis (now Cgen). Chair of two MedTech companies. PharmaVoice Top 100. Health Investor Power Top 50. EY Entrepreneur of the Year finalist.
    💼 Search "Natalie Douglas" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adamwalkerbiometrics

    #NatalieDouglas #HealthcareAtHome #Idis #ManagedAccess #PharmaPrescribed #AdamWalker #WomenInLeadership #FemaleFounder #Mentoring #PharmaLeadership #RealWorldEvidence #LifeSciences #NonExec #HealthcareInnovation #PatientAccess

    35 min
  • A Cancer Scare Showed Him How Impossible Finding a Trial Really Is

    Keith Berelowitz on PRxEngage, 35k Users in Month 1 & Why Patients Need North Star | Pharma Prescribed

    Dr. Keith Berelowitz — founder and CEO of PRx Engage — joins Adam Walker for a conversation about patient engagement, self-determination theory and what it actually takes to build a clinical trial matching platform that patients trust.

    Keith lost a friend at a young age. That drove him into science, then into bench research at the Royal Free, then into commercial clinical research at Richmond Pharmacology — where he and Adam first met. Years later, a personal cancer scare revealed how difficult it is to find a clinical trial, even for someone who works in the industry. PRx Engage was born from that experience.

    35,000+ users in the first month. Five days to full funding. Oversubscribed.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/6lhc5JvQJf2Vdg9kWeCQzT?si=5dd931e0eeeb4804
    Apple Podcasts → https://podcasts.apple.com/us/podcast/keith-berelowitz-on-prxengage-35k-users-in-month-1/id1829715970?i=1000727740938
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://pharmaprescribed.podbean.com/

    📖 WHAT WE COVER

    - A personal cancer scare — and realising even he got confused searching for trials
    - PRx Engage: no login, no friction, trials matched by condition, age and location
    - Self-determination theory: autonomy, competency and relatedness in patient engagement
    - The dating app analogy: swipe right, swipe left — and why showing multiple trials works
    - Decisional conflict and task completion: the three self-assessment tools
    - Why showing only one sponsor's trial is the wrong approach
    - 35,000+ users in month one — and a return rate of two to three visits
    - Five days to full funding, oversubscribed — investors bought the team
    - No login data collection: the ethos and the differentiator
    - Cycling around London on TikTok — and discovering it actually works
    - Trust across all stakeholders: why "them vs us" kills clinical research
    - Gene editing, one-and-done therapies and what the future holds for our children
    - "You can be direct without being disrespectful" — the golden rule

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Dr. Keith Berelowitz — founder of PRx Engage
    3:00 Losing a friend young — and why that drove everything
    4:00 A personal cancer scare and the search that changed his mind
    5:00 Leaving Richmond to build PRx Engage
    6:00 Purpose, ethics and paying it forward
    8:00 "I actually do like people" — understanding patient stories
    9:00 Authentic LinkedIn: writing everything himself
    10:00 Meeting everyone who asks — you never know what you'll learn
    12:00 Building a team that roams within a defined space
    14:00 Patient journey walkthrough: no login, condition, age, location
    16:00 Why showing multiple trials increases commitment
    17:00 Self-assessment: medical suitability, decisional conflict, task completion
    19:00 Mobile-first honesty — people tell their phone the truth
    20:00 Connecting to the research site: the only point data is collected
    22:00 Decentralised trials and travelling for research
    24:00 Gamification, retention and the patient who wants to join the dev team
    26:00 Startup lessons: highs and lows journal
    28:00 35,000 users, amazing engineering team and industry veterans
    30:00 Taking investment: five days to oversubscribed
    32:00 Building tech is more expensive than people realise
    34:00 "A patient's North Star" — resonating without pushing
    36:00 Social media strategy: LinkedIn first, TikTok cycling second
    38:00 Filming while cycling uphill — do not attempt
    40:00 Trust: the thing most lacking across all stakeholders
    42:00 Gene editing, one-and-done therapies and the next generation
    44:00 Quick-fire: stop trying to impress people who don't get you
    45:00 Low drama, high output — smart over slick
    46:00 Cycling as daily thinking time
    47:00 Golden rule: direct without disrespectful
    49:00 prxengage.com — and Keith's email is public

    👤 ABOUT DR. KEITH BERELOWITZ

    Founder and CEO of PRx Engage. Chair, Fulham Research Ethics Committee. 20+ years in pharma and biotech research. Former Operations Director at Richmond Pharmacology.
    🌐 https://www.prxengage.com
    💼 Search "Keith Berelowitz" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #KeithBerelowitz #PRxEngage #PatientEngagement #ClinicalTrials #PharmaPrescribed #AdamWalker #TrialMatching #SelfDeterminationTheory #PatientRecruitment #HealthTech #ClinicalResearch #LifeSciences #PatientAccess #StartupFounder #TrustInResearch

    47 min
  • Someone Has to Obsess Over the Rivets: The Detail That Protects a $1.6bn Trial

    Steve Sanghera on Inventus, Purpose-Built Trial Devices & Why Someone Must Obsess Over the Rivets | Pharma Prescribed

    Steve Sanghera — CEO of Inventus — joins Adam Walker for a conversation about purpose-built clinical trial devices, global connectivity and why this industry needs someone obsessing over the rivets.

    Steve came from mobile telecoms and finance. During COVID, a lost contract with Motorola led to a question: who needs this many devices? The answer was clinical trials. Half a million devices later, Inventus is the only dedicated clinical data plan operator in life sciences — carrier-agnostic connectivity across 135 countries, purpose-built hardware for patients and sites, and zero tolerance for the kind of failure rates consumer tech accepts.

    His sister was diagnosed with MS at 19. She's 42 now, in a wheelchair. Inventus wasn't built because of that — but it drives everything Steve does today.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/5V4MJJPemxVcC8zl0WOvWZ?si=1c9e14455bee4dc2
    Apple Podcasts → https://podcasts.apple.com/us/podcast/steve-sanghera-on-inventus-purpose-built-trial-devices/id1829715970?i=1000727055724
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://pharmaprescribed.podbean.com/

    📖 WHAT WE COVER

    - The Motorola loss that became the founding story of Inventus
    - 500,000 devices deployed globally — zero consumer returns
    - One world, one device: purpose-built for clinical trials, not repurposed consumer tech
    - The only clinical data plan operator: 450 carriers, 135 countries, no SIM cards
    - BYOD vs provisioned: why bring your own device is a cost saving, not a solution
    - Designing for Doris from Texas: 85, not tech savvy, possibly impaired
    - 586 languages on every device — four times more than any competitor
    - The rivets analogy: everyone builds the plane, Inventus provides the rivets
    - Service excellence with zero tolerance for failure in clinical trials
    - His sister's MS diagnosis at 19 — and declining every trial offered
    - The stigma around clinical trials and why it still stops families
    - 70 employees, offices in UK, EU, China, Hong Kong and the US
    - AstraZeneca's David Loughborough joining as Chief Strategy Officer
    - Inventus 2.0: AI, connected health and preventative care roadmap
    - "Build a business I can't run anymore" — that means success

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Steve Sanghera — CEO of Inventus
    2:00 Lockdown, Motorola and the accidental entry into clinical trials
    4:00 Purpose-built devices: why consumer tech doesn't work
    5:00 One world, one device — and the ecosystem behind it
    6:00 Patients, sites and sponsors: the three pillars
    8:00 BYOD vs provisioned — cost saving vs real solution
    9:00 Half the cost, full the value
    10:00 The clinical data plan operator: 450 carriers, 135 countries
    12:00 One product accessed globally — no SIM cards
    13:00 Service excellence: every client and key hire comes via referral
    14:00 Zero percent failure tolerance vs consumer 3-5%
    15:00 Regulation, compliance and learning the language of life sciences
    17:00 The biggest challenge: finding someone who cares about the rivets
    18:00 The rivets analogy: protecting $1.6 billion per trial
    20:00 Designing for Doris: user interface, font size, 586 languages
    22:00 NHS app frustrations and simplifying complexity
    24:00 From five people to 70 — three UK offices, EU, China, US
    25:00 New leadership: COO, CSO from AstraZeneca, CPO from BT
    27:00 "Our accountant joined us — that tells you the numbers are real"
    28:00 His sister's MS diagnosis at 19 and the trials they declined
    30:00 Clinical trial stigma and what must change
    32:00 AI: don't jump on it, mould it for clinical trials
    34:00 Inventus 2.0: building the oven, figuring out how to cook
    37:00 "Build a business I can't run anymore"
    38:00 The All Blacks: leaving the shirt in a better place
    39:00 Quick-fire: should have started earlier
    40:00 Integrity, loyalty, hard work — and shopping
    41:00 Golden rule: be honest and transparent

    👤 ABOUT STEVE SANGHERA

    CEO of Inventus. Purpose-built clinical trial devices and the only dedicated clinical data plan operator in life sciences.
    🌐 Search "Inventus clinical trials" or "Steve Sanghera" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #SteveSanghera #Inventus #ClinicalTrials #MedicalDevices #PharmaPrescribed #AdamWalker #ClinicalTechnology #BYOD #PatientDevices #GlobalConnectivity #eSIM #LifeSciences #DrugDevelopment #PurposeBuilt #ServiceExcellence

    42 min
  • 2,000 Videos In: Why Trust Is the Ultimate Cheat Code in Healthcare

    Dr. Berry Pierre on Main Character Energy, 2k YouTube Vids & Trust in Healthcare | Pharma Prescribed

    Dr. Berry Pierre — board certified internist, host of the Lunch and Learn Podcast and digital health educator with over 2,000 YouTube videos — joins Adam Walker for one of the most energising conversations on the Pharma Prescribed Podcast.

    Dr. Berry grew up in a Haitian community in the US, inspired by his childhood paediatrician Dr. Gasstone — the community physician who spoke their language and their truth. He decided at elementary school he wanted to be a doctor, never had a plan B, and never looked back. Fifteen years into clinical practice, he realised he couldn't help the whole community one patient at a time — so he started going live on Facebook during his lunch hour, twice a week, and built a digital health empire from there.

    His golden rule: be trustworthy, be responsible, and add a pinch of confidence.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/0NocvLEShLPb2vJQdR5zN3?si=-acv27f3RlmRdX0fALfnnQ
    Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-dr-berry-pierre-fact-versus/id1829715970?i=1000723106007
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://www.podbean.com/eas/pb-rm3xz-193fa5c

    📖 WHAT WE COVER

    - Dr. Gasstone: the Haitian community physician who inspired everything
    - Main character energy — and where it comes from
    - Systematic barriers: time, insurance, language and cultural competency
    - The lunch hour cheat code: Facebook Live on Tuesdays and Thursdays
    - 2,000+ YouTube videos and the Lunch and Learn Podcast at 400+ episodes
    - Patients trusting him before they've even met him
    - Vaccine hesitancy, pop culture and public health
    - Cultural competency in Haitian and underserved communities
    - The future of AI in community health education
    - Be okay with not being right 100% of the time — advice to a younger self
    - Speed, reliability and the ability to build trust — team qualities
    - PlayStation, strategy games and Harry Potter as decompression

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Dr. Berry Pierre — board certified internist
    2:00 Main character energy and Dr. Gasstone
    3:00 No plan B — doctor from elementary school
    4:00 Systematic barriers: time, insurance, language
    5:00 The lunch hour cheat code: Facebook Live twice a week
    6:00 One to many — scaling trust through content
    8:00 Serving Haitian communities and cultural competency
    12:00 Vaccine hesitancy and pop culture meets public health
    16:00 2,000 YouTube videos and what keeps him going
    20:00 AI in community health education
    24:00 Why trust is the ultimate cheat code
    28:00 Comparing US and UK healthcare access
    32:00 The Empower Yourself for Better Health series
    36:00 Quick-fire: be okay with not being right all the time
    38:00 Speed, reliability and building trust as team values
    40:00 PlayStation, God of War and Harry Potter
    42:00 Golden rule: trustworthy, responsible, pinch of confidence
    43:00 drberrypierre.com and closing thanks

    👤 ABOUT DR. BERRY PIERRE

    Board certified internist. Host of the Lunch and Learn with Berry Podcast (400+ episodes). 2,000+ YouTube videos. 15+ years of clinical practice.
    🌐 https://www.drberrypierre.com
    💼 Search "Dr Berry Pierre" on LinkedIn and YouTube

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #DrBerryPierre #LunchAndLearn #DigitalHealth #PublicHealth #PharmaPrescribed #AdamWalker #PatientEducation #CulturalCompetency #HealthEquity #VaccineHesitancy #CommunityHealth #MainCharacterEnergy #LifeSciences #YouTube #Podcast

    50 min

About Adam Walker’s Pharma Prescribed Podcast

From the publisher's feed

Get ready for open and honest long-form conversations with fascinating and passionate individuals in clinical research.
These are people you may or may not be aware of, with one thing in common -…